for pain and other conditions, announced the appointment of leading experts to its newly formed scientific advisory board (SAB). The members of Egalet's scientific advisory board include: Vincent Lee, Ph.D., D.Sc. research professor and former director of the School of Pharmacy at the Chinese University of Hong Kong and former chairman of the department of pharmaceutical sciences at the School of Pharmacy at the University of Southern California; Jacques-Pierre Moreau, D.Sc., former founder and president of Biomeasure Inc. and chief scientific officer and executive vice president of Ipsen SA (France); Nicholas Nicolaides, Ph.D., president, chief executive officer and co-founder of Morphotek; Kenneth Shea, Ph.D., professor of chemistry at the School of Physical Science at the University of California, Irvine; Giovanni Traverso, M.D., Ph.D., instructor in medicine at Harvard Medical School, a gastroenterologist at the Massachusetts General Hospital and a research affiliate at the Massachusetts Institute of Technology; and Jeffrey Wilkins, M.D., chief medical officer of Lycera.

The newly formed SAB will serve as a strategic resource to Egalet regarding the numerous potential applications of its Guardian Technology.